These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29858461)

  • 1. Flare of a Cryopyrin-associated Periodic Syndrome Following Vaccination with Neisseria Meningitidis Polysaccharides.
    Walker UA; Luetke Volksbeck S; Kuemmerle-Deschner J
    J Rheumatol; 2018 Jun; 45(6):878-879. PubMed ID: 29858461
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of meningococcal B vaccines.
    Prescrire Int; 2014 Sep; 23(152):204. PubMed ID: 25325114
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reactivation of the cryopyrin-associated periodic syndrome after vaccination in a patient who is a candidate for immunosuppression].
    Fernández-Prada M; Rugeles-Niño J; Suárez-Pérez L; Ruiz-Álvarez M; López-Díaz JB; Fernández-Madera J; Martínez-Ortega C; Huerta-González I
    Rev Esp Quimioter; 2019 Aug; 32(4):379-380. PubMed ID: 31241279
    [No Abstract]   [Full Text] [Related]  

  • 4. Whole cell vaccination for meningococcus: Lessons from an idea whose time has gone.
    Labrie JE; Keiser PB
    Hum Vaccin; 2010 Apr; 6(4):360-5. PubMed ID: 20372072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine offers meningitis hope.
    Butler D
    Nature; 2010 Nov; 468(7321):143. PubMed ID: 21068797
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduction in Neisseria meningitidis infection in Italy after Meningococcal C conjugate vaccine introduction: A time trend analysis of 1994-2012 series.
    de Waure C; Miglietta A; Nedovic D; Mereu G; Ricciardi W
    Hum Vaccin Immunother; 2016; 12(2):467-73. PubMed ID: 26308192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
    Cohen R; Levy C
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for vaccine prevention of meningococcal infection.
    Harrison LH
    Clin Microbiol Rev; 2006 Jan; 19(1):142-64. PubMed ID: 16418528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of group C meningococcal vaccine.
    Commun Dis Rep CDR Wkly; 2000 Sep; 10(35):311, 314. PubMed ID: 10992627
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of group B meningococcal disease by vaccination: a difficult task.
    Thomas M
    N Z Med J; 2004 Aug; 117(1200):U1016. PubMed ID: 15475986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis.
    Munguambe AM; de Almeida AECC; Nhantumbo AA; Come CE; Zimba TF; Paulo Langa J; de Filippis I; Gudo ES
    PLoS One; 2018; 13(8):e0197390. PubMed ID: 30089105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil.
    Nunes AM; Ribeiro GS; Ferreira ÍE; Moura AR; Felzemburgh RD; de Lemos AP; Reis MG; de Moraes JC; Campos LC
    PLoS One; 2016; 11(11):e0166475. PubMed ID: 27861618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fighting Neisseria meningitidis: past and current vaccination strategies.
    Piccini G; Torelli A; Gianchecchi E; Piccirella S; Montomoli E
    Expert Rev Vaccines; 2016 Nov; 15(11):1393-1407. PubMed ID: 27158988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Workshop on vaccine pressure and Neisseria meningitidis, Annecy, France, 9-11 March 2005.
    Alonso JM; Gilmet G; Rouzic EM; Nassif X; Plotkin SA; Ramsay M; Siegrist CA; Stephens DS; Teyssou R; Vogel U
    Vaccine; 2007 May; 25(21):4125-9. PubMed ID: 17449149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal vaccines: Current state and future outlook.
    Leca M; Bornet C; Montana M; Curti C; Vanelle P
    Pathol Biol (Paris); 2015 Jun; 63(3):144-51. PubMed ID: 25986879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential impact of vaccination against Neisseria meningitidis on Neisseria gonorrhoeae in the United States: results from a decision-analysis model.
    Régnier SA; Huels J
    Hum Vaccin Immunother; 2014; 10(12):3737-45. PubMed ID: 25483706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England.
    Ladhani SN; Giuliani MM; Biolchi A; Pizza M; Beebeejaun K; Lucidarme J; Findlow J; Ramsay ME; Borrow R
    Emerg Infect Dis; 2016 Feb; 22(2):309-11. PubMed ID: 26811872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination strategies for the prevention of meningococcal disease.
    Vuocolo S; Balmer P; Gruber WC; Jansen KU; Anderson AS; Perez JL; York LJ
    Hum Vaccin Immunother; 2018 May; 14(5):1203-1215. PubMed ID: 29543535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients.
    Wyplosz B; Derradji O; Hong E; François H; Durrbach A; Duclos-Vallée JC; Samuel D; Escaut L; Launay O; Vittecoq D; Taha MK
    Transpl Infect Dis; 2015 Apr; 17(2):322-7. PubMed ID: 25645691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study.
    Klein NP; Habanec T; Kosina P; Shah NR; Kolhe D; Miller JM; Hezareh M; Van der Wielen M
    Vaccine; 2018 Apr; 36(17):2356-2363. PubMed ID: 29576307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.